Kenneth Londoner - Mar 30, 2022 Form 4 Insider Report for BioSig Technologies, Inc. (BSGM)

Role
Chief Executive Officer, Director
Signature
/s/ Kenneth L. Londoner, attorney-in-fact
Stock symbol
BSGM
Transactions as of
Mar 30, 2022
Transactions value $
$0
Form type
4
Date filed
4/8/2022, 06:25 PM
Previous filing
Jan 3, 2022
Next filing
May 24, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSGM Restricted Stock Award $0 +400K $0.00 400K Mar 30, 2022 Common Stock 400K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of restricted stock shall be fully vested as of March 30, 2022, the date of the grant.